Used primarily as a broad-spectrum antibiotic in clinical settings, this compound is effective against a wide range of Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa. It is commonly administered intravenously to treat severe infections such as pneumonia, septicemia, intra-abdominal infections, and urinary tract infections, especially in hospitalized patients. Often combined with a beta-lactamase inhibitor like tazobactam, it overcomes bacterial resistance mechanisms, enhancing its efficacy. Its use is particularly important in immunocompromised patients and in managing nosocomial infections where resistant pathogens are prevalent.